H1N1 Beijing

H1N1 Influenza-A Virus Beijing/262/95
Cat. No.
BT25259
Source
Synonyms
Appearance

Opaque suspension.

Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Beijing/262/95. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

Product Specs

Introduction
H1N1, a subtype of Influenza A virus, has mutated into various strains affecting humans, pigs, and birds. These include the Spanish Flu strain, mild human flu strains, endemic pig strains, and avian strains. Influenza A Virus is a globular particle, approximately 100nm in diameter, enclosed in a lipid bilayer derived from its host's plasma membrane. Embedded within this bilayer are two integral membrane proteins: around 500 molecules of hemagglutinin (H) and about 100 molecules of neuraminidase (N). Internally, the virus contains 3000 molecules of matrix protein, 8 RNA segments, and numerous copies of nucleoprotein. Each RNA segment is associated with multiple copies of nucleoprotein, RNA polymerase subunits, and other non-structural proteins with unclear functions.
Description
This product contains allantoic fluid harvested from 10-day-old embryonated eggs inoculated with the A/Beijing/262/95 strain of Influenza A virus. The virus was purified using ultracentrifugation with a 10-40% sucrose gradient.
Inactivation
This product has been treated with thimerosal and beta-propiolactone to inactivate the virus. While this treatment is in line with established inactivation methods, it is essential to follow standard laboratory practices for handling microbiological and viral agents.
Physical Appearance
Opaque suspension
Formulation
The H1N1 A/Beijing/262/95 solution is supplied in STE buffer containing 0.09% sodium azide (NaN3) and 0.005% thimerosal. Ensure thorough mixing before use.
Stability
For optimal stability, store H1N1 A/Beijing/262/95 below -18°C. Although it can remain stable at 4°C for up to 4 weeks, repeated freeze-thaw cycles should be avoided.
Purity
Purity of this product exceeds 90%, as determined by SDS-PAGE analysis.
Immunological Activity
Serological studies of influenza A virus, immunogen for antibody production.Tested with anti-influenza A monoclonal antibodies in ELISA.

Product Science Overview

Introduction

The H1N1 Influenza-A Virus Beijing/262/95 is a strain of the H1N1 subtype of the Influenza A virus. This particular strain was isolated in Beijing, China, in 1995. Influenza A viruses are known for their ability to cause significant respiratory illnesses in humans and animals, and the H1N1 subtype has been responsible for several pandemics throughout history.

Historical Context

The H1N1 influenza virus has a long history, dating back to the 1918 Spanish flu pandemic, which caused millions of deaths worldwide . Over the years, the H1N1 virus has undergone numerous genetic changes, leading to the emergence of various strains. The Beijing/262/95 strain is one of these variants, which has been studied for its unique genetic and antigenic properties .

Genetic and Antigenic Characteristics

The H1N1 Influenza-A Virus Beijing/262/95 belongs to the delta-like clade of the swine H1 lineage . Genetic analyses have shown that this strain has distinct genetic markers that differentiate it from other H1N1 strains. The hemagglutinin (HA) protein, which is responsible for the virus’s ability to bind to host cells, has been a focal point of research. The HA protein of the Beijing/262/95 strain has been expressed in various host systems for study and reagent production .

Geographic Distribution

Since its isolation in 1995, the Beijing/262/95 strain has remained geographically restricted to Asia . This limited distribution contrasts with other H1N1 strains, which have spread globally. The reasons for this geographic restriction are not entirely understood but may be related to specific genetic and antigenic properties of the strain.

Impact and Research

The H1N1 Influenza-A Virus Beijing/262/95 has been the subject of various research studies aimed at understanding its genetic makeup and potential impact on public health. Researchers have used this strain to study mutation accumulation and the evolutionary dynamics of the H1N1 virus . These studies have provided valuable insights into the mechanisms of viral evolution and the factors that influence the emergence and spread of new influenza strains.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.